1. Home
  2. ITRM vs UG Comparison

ITRM vs UG Comparison

Compare ITRM & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.31

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$7.32

Market Cap

27.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
UG
Founded
2015
1942
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
27.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ITRM
UG
Price
$0.31
$7.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
497.5K
9.5K
Earning Date
03-20-2026
03-20-2026
Dividend Yield
N/A
6.51%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
$390,000.00
$10,060,322.00
Revenue This Year
N/A
N/A
Revenue Next Year
$193.01
N/A
P/E Ratio
N/A
$18.00
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$5.58
52 Week High
$1.62
$11.54

Technical Indicators

Market Signals
Indicator
ITRM
UG
Relative Strength Index (RSI) 42.44 67.53
Support Level $0.31 $6.25
Resistance Level $0.37 $7.70
Average True Range (ATR) 0.03 0.24
MACD 0.00 0.11
Stochastic Oscillator 9.44 74.50

Price Performance

Historical Comparison
ITRM
UG

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: